Top Complementary and Alternative Medicine Companies

Complementary and Alternative Medicine Market size was valued at USD 189.77 Billion in 2024 and is poised to grow from USD 236.45 Billion in 2025 to USD 1373.69 Billion by 2033, growing at a CAGR of 24.6% during the forecast period (2026–2033).

The increasing number of players in the worldwide complementary and alternative medicine market is anticipated to increase investments in the development, marketing, and distribution of CAM products on a global scale. Additionally, the market expansion is anticipated to be fueled by a variety of development methods used by these market competitors, such as new product launches, partnerships, collaborations, and mergers. Market participants are always looking for ways to dominate the industry and get an advantage over rivals. 'Nature's Bounty Co. (US)', 'iHerb, Inc. (US) ', 'Swanson Health Products (US) ', 'Gaia Herbs (US) ', 'Herb Pharm (US) ', 'Boiron (France) ', 'Himalaya Wellness Company (India) ', 'Dabur India Ltd. (India) ', 'Patanjali Ayurved Ltd. (India) ', 'Tsumura & Co. (Japan) ', 'Schwabe Pharma GmbH & Co. KG (Germany) ', 'Weleda (Switzerland) ', 'Standard Process Inc. (US) ', 'Metagenics, Inc. (US) ', 'Pure Encapsulations, LLC (US) ', 'Nordic Naturals (US) ', 'NOW Foods (US) ', 'Solgar (US) ', 'Nutraceutical Corporation (US) ', 'USANA Health Sciences, Inc. (US)'

The prevalence of various chronic diseases like cancer and cardiovascular diseases is increasing, and complementary and alternative medicines and therapies are becoming more and more popular. These factors, along with the rising costs of conventional medications and their side effects, are what are driving the growth of the global complementary and alternative medicine market.

The focus of CAM medicine will almost definitely remain on creating fresh cancer treatments. Oncological conditions are treated with CAM medicine 30% more frequently than the next most common use. Applications of CAM medicine in cancer are more prevalent in Europe and the US, where research is done. Government funding is expected to hasten the growth of the CAM medicine sector in the field of sickness treatment.

Europe held the largest share of the global complementary and alternative medicine market in 2021. The rise of the CAM business in Europe has been aided by consumers' greater use of alternative therapies and declining reliance on current pharmaceuticals. Additionally, as consumers become more aware of the long-term negative consequences of chemically based medications, they are turning to herbal, Ayurvedic, and naturopathic remedies. Additionally, it is predicted that the growing popularity of acupuncture and yoga in Europe will maintain the region's prominence in the market for the duration of the projected period. In addition, during the past 20 years, hospitals offering complementary and alternative treatment have increased in number across Europe.